Sutro Biopharma Inc
F:S09
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sutro Biopharma Inc
F:S09
|
US |
|
G
|
Gilat Satellite Networks Ltd
XMUN:GSA
|
IL |
|
K
|
KKR Real Estate Finance Trust Inc
F:8KR
|
US |
|
J
|
Janus Henderson Group PLC
F:HDJA
|
UK |
|
Ependion AB
F:TW4
|
SE |
Wall St Price Targets
S09 Price Targets Summary
Sutro Biopharma Inc
According to Wall Street analysts, the average 1-year price target for
S09 is 1.41 EUR with a low forecast of 0.29 EUR and a high forecast of 1.85 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is S09's stock price target?
Price Target
1.41
EUR
According to Wall Street analysts, the average 1-year price target for
S09 is 1.41 EUR with a low forecast of 0.29 EUR and a high forecast of 1.85 EUR.
What is the Revenue forecast for Sutro Biopharma Inc?
Projected CAGR
20%
Over the last 8 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 20%.